Aeon Biopharma (AEON) shares were up more than 39% in Thursday's premarket activity after the company announced positive data from a pilot forced degradation study for its lead drug candidate, ABP-450.
Culp (CULP) stock was 19% higher after the company swung to fiscal Q1 earnings and higher revenue.
Golden Heaven Group (GDHG) shares up were more than 15% after a 4.3% rise in the prior session.
Vince (VNCE) stock was 11% higher after the company's Q2 results.
Alumis (ALMS) shares were up more than 6%, swinging from a 7.4% fall at the previous close.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.